Navigation Links
Supplemental New Drug Application Submitted to FDA for NUCYNTA® ER (Tapentadol) Extended-Release Tablets for Diabetic Peripheral Neuropathic Pain
Date:10/31/2011

course of patients with head injury due to effects on pupillary response and consciousness. NUCYNTA® ER should be used with caution in patients with head injury, intracranial lesions, or other sources of preexisting increased intracranial pressure.
  • Tapentadol is a mu-opioid agonist and is a Schedule II controlled substance. Such drugs are sought by drug abusers and people with addiction disorders. Diversion of Schedule II products is an act subject to criminal penalty.
  • Patients should be assessed for their clinical risks for opioid abuse or addiction prior to being prescribed opioids.
  • NUCYNTA® ER can be abused in a manner similar to other opioid agonists, legal or illicit. This should be considered when prescribing or dispensing NUCYNTA® ER in situations where the physician or pharmacist is concerned about an increased risk of misuse and abuse. Concerns about abuse and addiction should not prevent the proper management of pain. However, all patients treated with mu-opioid agonists require careful monitoring for signs of abuse and addiction, since use of mu-opioid agonist analgesic products carries the risk of addiction even under appropriate medical use.
  • Drug abusers may attempt to abuse NUCYNTA® ER by crushing, chewing, snorting, or injecting the product. These practices may result in the uncontrolled delivery of NUCYNTA® ER and pose a significant risk to the abuser that could result in overdose and death.
  • NUCYNTA® ER may cause severe hypotension. Patients at higher risk of hypotension include those with hypovolemia or those taking concurrent products that compromise vasomotor tone (eg, phenothiazines, general anesthetics).
  • Patients should be cautioned that NUCYNTA® ER may impair the mental and/or physical abilities required for the performance of potentially hazardous tasks such as driving a car or operating machinery. This is to be expected, especially at the beginning of treatment, at any change of dosa
    '/>"/>

  • SOURCE Janssen Pharmaceuticals Research & Development
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

    Related medicine technology :

    1. Abbott Receives Supplemental FDA Approval for its Best-in-Class in Sensitivity RealTime HIV-1 Viral Load Test
    2. ORENCIA(R) (abatacept) Supplemental Biologics License Application for Juvenile Idiopathic Arthritis Accepted by FDA for Filing and Review
    3. FDA Accepts Wyeths Supplemental New Drug Application for Tygacil for the Treatment of Patients with Community-Acquired Pneumonia
    4. Supplemental New Drug Application for PREZISTA(TM) Submitted to U.S. Food and Drug Administration
    5. Lilly Submits Cymbalta(R) Supplemental New Drug Application for Chronic Pain to U.S. Food and Drug Administration
    6. CTI to Meet With the FDA to Discuss Filing of a Supplemental Biologics License Application for Zevalin(R)
    7. Anesiva Announces FDA Approval of Supplemental New Drug Application to Expand Zingo(TM) Indication
    8. FDA Grants Priority Review of a Supplemental Biologics License Application for Cinryze(TM) C1 Inhibitor (Human) as Treatment for Acute Attacks of Hereditary Angioedema (HAE)
    9. Cephalon Submits NUVIGIL Supplemental New Drug Application for the Treatment of Excessive Sleepiness Associated with Jet Lag Disorder
    10. Sanofi Pasteur Submits Supplemental Application for A(H1N1) Pandemic Vaccine to U.S. FDA
    11. Cephalon Announces that FDA Grants Priority Review of its Supplemental New Drug Application for NUVIGIL as a Treatment for Excessive Sleepiness Associated with Jet Lag Disorder
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:11/28/2014)... -- Chinese magnesium alloy maker DongGuan Eontec Co., Ltd ... bone fixation screw has received Chinese regulatory inspection approval ... and that the company acknowledges receipt of the approval ... and Technology Daily journalists Wang Xiangming and ... Professor Li Yangde , has been a pioneer ...
    (Date:11/27/2014)... - New Solution That Makes JINS MEME,s Raw ... Ltd. will launch JINS MEME "ACADEMIC PACK" in late April, ... (without tax /including two pairs of JINS MEME and designated ... of "JINS MEME" to academic researchers, and it enables them ... and six-axis sensors without API. (*Physiological data that can be ...
    (Date:11/26/2014)... Company plc ("Perrigo") (NYSE: PRGO ; TASE), ... today announced the closing of Perrigo,s previously announced registered ... shares at a public offering price of $152.00 per ... purchase up to an additional 888,157 ordinary shares by ... representatives of the several underwriters. Perrigo ...
    Breaking Medicine Technology:Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 2Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 3Chinese magnesium alloy manufacturer Eontec expects to have its medical magnesium alloy available for clinical trial in 2015 4JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 2JIN to Launch JINS MEME ACADEMIC PACK in Late April 2015 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 2Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 3Perrigo Company plc Announces The Closing Of Its Registered Public Offering Of Ordinary Shares 4
    ... Texas, Nov. 18, 2010 OCuSOFT, Inc., an ... to announce that ZYTAZE™ is now available in ... but are not limited to: Walgreens, CVS, Wal-Mart, ... In an early pilot study, ZYTAZE™ demonstrated marked ...
    ... FORD, Pa., Nov. 18, 2010 Endo Pharmaceuticals Holdings ... it priced $400 million aggregate principal amount of 7.00% ... of 99.10 percent in connection with its previously announced ... of the Company and will be guaranteed by certain ...
    Cached Medicine Technology:Endo Pharmaceuticals Holdings Inc. Announces Pricing of Private Offering of Senior Notes 2
    (Date:11/28/2014)... diabetes face a number of challenges over the holidays, but ... "With the holidays coming, take some time to think ... be visiting and all of the to-dos," Joan Bardsley, president ... association news release. "By planning ahead. you can enjoy the ... make a healthy eating contract with yourself. Before a big ...
    (Date:11/28/2014)... Agein.com, the Internet’s premier anti-aging web site ... the foremost experts in the industry, is releasing its top ... winter. , “The official start of winter is still three ... hit with an icy blast. After one of the worst ... will usher in another brutal winter,” says Dr. Kevin J. ...
    (Date:11/28/2014)... BambooFlooringChina.com has been recognized as a ... the business has announced its new strand woven ... discount on these new models. , Based on the ... without carpenter machines involved. It is crafted on strand ... for do-it-yourselfers without hard work on installation, also available ...
    (Date:11/28/2014)... Now that the holiday season is here, ... nation's leading cash-for-junk-cars companies, is improving their cash offers ... competitive and help bring a little bit more joy ... year. , Along with purchasing expensive gifts for family ... deal with large travel expenses during the holiday season. ...
    (Date:11/28/2014)... 28, 2014 Dr. Diane Walder, one ... announced the addition of Dr. Bridgit Nolan to her ... practice after having completed her dermatology residency at the ... Walder invited Dr. Nolan to join her ... and cosmetic dermatology. Not only does Dr. Nolan strive ...
    Breaking Medicine News(10 mins):Health News:Holiday Eating Tips for People With Diabetes 2Health News:Agein Corporation, a Leading Anti-Aging Company, Releases Top Diet and Personal Care Tips for Preventing Dry Skin this Season 2Health News:BambooFlooringChina.com Introduces Its New Strand Woven Bamboo Flooring Collection 2Health News:Rusty's Auto Salvage Increasing Their Cash Offers to Help Drivers Save Throughout the Busy Holiday Season 2Health News:Dr. Diane Walder Welcomes New Cosmetic Dermatologist to Practice 2
    ... Treatment ... Worldwide, LOS ANGELES, Nov. ... develop an AIDS vaccine have,announced that their efforts have stumbled or, in ... was halted last week,when its vaccine was suspected of actually making some ...
    ... erosive gastroesophageal reflux disease ... (GERD) who cannot swallow tablets, COLLEGEVILLE, Pa., ... WYE ), announced today that the,U.S. Food and Drug Administration ... new addition,to the Protonix family of prescription medications. "The ...
    ... The prognosis for individuals with metastatic melanoma (MM) is ... have some clinical benefit; however, most patients eventually succumb ... known as dendritic cells (DCs) fail to sustain an ... in vitro using human melanoma cell lines and resected ...
    ... YORK, Nov. 15 Danny Wright, Chief Executive ... (http://www.alliancehealthcard.com ) will be featured in an exclusive ... at 2 p.m. EST. The interview,will be posted ... on November 16. The interview will cover ...
    ... will serve as Digital,s Medical Director for ... Ophthalmology, ... company specializing in retinal risk assessment for diabetics,announced today that Suber S. ... provide the company expert,advice and counsel regarding product development and development. ...
    ... consumption of these foods lowered odds up to 60%, study ... that includes plenty of fish, omega-3 rich oils, fruits and ... while high intake of omega-6 rich oils may boost the ... They looked at the diets of 8,085 people older than ...
    Cached Medicine News:Health News:AIDS Vaccine Failures Highlight Need to Focus on Lifesaving Treatment, Says AHF 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 2Health News:Wyeth Receives FDA Approval of Protonix for Delayed-Release Oral Suspension 3Health News:WallSt.net Announces Upcoming Interview With CEO of Alliance HealthCard 2Health News:Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director 2Health News:Digital Healthcare Announces Appointment of Dr. Suber Huang as Medical Director 3Health News:Fish, Fruits, Veggies May Cut Dementia Risk 2
    ... Practice management software for eyecare ... true multi-tasking, multi-office practice management ... database technology- Winx Pro is ... assist you in effectively managing ...
    ... Working with over 2,500 ... proud to serve one ... client bases in the ... PM Ophthalmology, we are ...
    ... EMR Ophthalmology is a comprehensive electronic ... for ophthalmology practices. Intuition EMR Ophthalmology ... provides the tools to evaluate your ... to make better decisions and to ...
    ... in advanced cartridge mixing and delivery systems. ... mechanically injects all types of bone cement ... line-up includes a large selection of nozzles ... difficult to access areas. A new, anatomically ...
    Medicine Products: